1. Home
  2. RCMT vs CDXS Comparison

RCMT vs CDXS Comparison

Compare RCMT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$18.51

Market Cap

150.7M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.20

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
CDXS
Founded
1971
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
150.7M
141.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
RCMT
CDXS
Price
$18.51
$1.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
47.0K
1.2M
Earning Date
03-11-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$309,840,000.00
$52,932,000.00
Revenue This Year
$16.29
$15.64
Revenue Next Year
$6.92
$5.23
P/E Ratio
$10.72
N/A
Revenue Growth
13.70
N/A
52 Week Low
$13.18
$1.12
52 Week High
$28.27
$4.46

Technical Indicators

Market Signals
Indicator
RCMT
CDXS
Relative Strength Index (RSI) 27.81 39.00
Support Level $17.26 $1.12
Resistance Level $21.41 $1.36
Average True Range (ATR) 0.74 0.12
MACD -0.32 -0.01
Stochastic Oscillator 3.86 29.41

Price Performance

Historical Comparison
RCMT
CDXS

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: